Nurse practitioner and physician assistant interest in prescribing buprenorphine

Robert J. Roose, Hillary V. Kunins, Nancy L. Sohler, Rashiah T. Elam, Chinazo O. Cunningham

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Office-based buprenorphine places health care providers in a unique position to combine HIV and drug treatment in the primary care setting. However, federal legislation restricts nurse practitioners (NPs) and physician assistants (PAs) from prescribing buprenorphine, which may limit its potential for uptake and inhibit the role of these nonphysician providers in delivering drug addiction treatment to patients with HIV. This study aimed to examine the level of interest in prescribing buprenorphine among nonphysician providers. We anonymously surveyed providers attending HIV educational conferences in six large U.S. cities about their interest in prescribing buprenorphine. Overall, 48.6% (n = 92) of nonphysician providers were interested in prescribing buprenorphine. Compared to infectious disease specialists, nonphysician providers (adjusted odds ratio [AOR] = 2.89, 95% confidence interval [CI] = 1.22-6.83) and generalist physicians (AOR = 2.04, 95% CI = 1.09-3.84) were significantly more likely to be interested in prescribing buprenorphine. NPs and PAs are interested in prescribing buprenorphine. To improve uptake of buprenorphine in HIV settings, the implications of permitting nonphysician providers to prescribe buprenorphine should be further explored.

Original languageEnglish (US)
Pages (from-to)456-459
Number of pages4
JournalJournal of Substance Abuse Treatment
Volume34
Issue number4
DOIs
StatePublished - Jun 2008

Fingerprint

Physician Assistants
Buprenorphine
Nurse Practitioners
HIV
Odds Ratio
Confidence Intervals
Legislation
Health Personnel
Substance-Related Disorders
Communicable Diseases
Primary Health Care
Physicians

Keywords

  • Buprenorphine
  • HIV
  • Nurse practitioners
  • Opioid dependence
  • Substance abuse

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Nurse practitioner and physician assistant interest in prescribing buprenorphine. / Roose, Robert J.; Kunins, Hillary V.; Sohler, Nancy L.; Elam, Rashiah T.; Cunningham, Chinazo O.

In: Journal of Substance Abuse Treatment, Vol. 34, No. 4, 06.2008, p. 456-459.

Research output: Contribution to journalArticle

Roose, Robert J. ; Kunins, Hillary V. ; Sohler, Nancy L. ; Elam, Rashiah T. ; Cunningham, Chinazo O. / Nurse practitioner and physician assistant interest in prescribing buprenorphine. In: Journal of Substance Abuse Treatment. 2008 ; Vol. 34, No. 4. pp. 456-459.
@article{ee484cce68ca4c449162a4dbd82131d6,
title = "Nurse practitioner and physician assistant interest in prescribing buprenorphine",
abstract = "Office-based buprenorphine places health care providers in a unique position to combine HIV and drug treatment in the primary care setting. However, federal legislation restricts nurse practitioners (NPs) and physician assistants (PAs) from prescribing buprenorphine, which may limit its potential for uptake and inhibit the role of these nonphysician providers in delivering drug addiction treatment to patients with HIV. This study aimed to examine the level of interest in prescribing buprenorphine among nonphysician providers. We anonymously surveyed providers attending HIV educational conferences in six large U.S. cities about their interest in prescribing buprenorphine. Overall, 48.6{\%} (n = 92) of nonphysician providers were interested in prescribing buprenorphine. Compared to infectious disease specialists, nonphysician providers (adjusted odds ratio [AOR] = 2.89, 95{\%} confidence interval [CI] = 1.22-6.83) and generalist physicians (AOR = 2.04, 95{\%} CI = 1.09-3.84) were significantly more likely to be interested in prescribing buprenorphine. NPs and PAs are interested in prescribing buprenorphine. To improve uptake of buprenorphine in HIV settings, the implications of permitting nonphysician providers to prescribe buprenorphine should be further explored.",
keywords = "Buprenorphine, HIV, Nurse practitioners, Opioid dependence, Substance abuse",
author = "Roose, {Robert J.} and Kunins, {Hillary V.} and Sohler, {Nancy L.} and Elam, {Rashiah T.} and Cunningham, {Chinazo O.}",
year = "2008",
month = "6",
doi = "10.1016/j.jsat.2007.05.009",
language = "English (US)",
volume = "34",
pages = "456--459",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Nurse practitioner and physician assistant interest in prescribing buprenorphine

AU - Roose, Robert J.

AU - Kunins, Hillary V.

AU - Sohler, Nancy L.

AU - Elam, Rashiah T.

AU - Cunningham, Chinazo O.

PY - 2008/6

Y1 - 2008/6

N2 - Office-based buprenorphine places health care providers in a unique position to combine HIV and drug treatment in the primary care setting. However, federal legislation restricts nurse practitioners (NPs) and physician assistants (PAs) from prescribing buprenorphine, which may limit its potential for uptake and inhibit the role of these nonphysician providers in delivering drug addiction treatment to patients with HIV. This study aimed to examine the level of interest in prescribing buprenorphine among nonphysician providers. We anonymously surveyed providers attending HIV educational conferences in six large U.S. cities about their interest in prescribing buprenorphine. Overall, 48.6% (n = 92) of nonphysician providers were interested in prescribing buprenorphine. Compared to infectious disease specialists, nonphysician providers (adjusted odds ratio [AOR] = 2.89, 95% confidence interval [CI] = 1.22-6.83) and generalist physicians (AOR = 2.04, 95% CI = 1.09-3.84) were significantly more likely to be interested in prescribing buprenorphine. NPs and PAs are interested in prescribing buprenorphine. To improve uptake of buprenorphine in HIV settings, the implications of permitting nonphysician providers to prescribe buprenorphine should be further explored.

AB - Office-based buprenorphine places health care providers in a unique position to combine HIV and drug treatment in the primary care setting. However, federal legislation restricts nurse practitioners (NPs) and physician assistants (PAs) from prescribing buprenorphine, which may limit its potential for uptake and inhibit the role of these nonphysician providers in delivering drug addiction treatment to patients with HIV. This study aimed to examine the level of interest in prescribing buprenorphine among nonphysician providers. We anonymously surveyed providers attending HIV educational conferences in six large U.S. cities about their interest in prescribing buprenorphine. Overall, 48.6% (n = 92) of nonphysician providers were interested in prescribing buprenorphine. Compared to infectious disease specialists, nonphysician providers (adjusted odds ratio [AOR] = 2.89, 95% confidence interval [CI] = 1.22-6.83) and generalist physicians (AOR = 2.04, 95% CI = 1.09-3.84) were significantly more likely to be interested in prescribing buprenorphine. NPs and PAs are interested in prescribing buprenorphine. To improve uptake of buprenorphine in HIV settings, the implications of permitting nonphysician providers to prescribe buprenorphine should be further explored.

KW - Buprenorphine

KW - HIV

KW - Nurse practitioners

KW - Opioid dependence

KW - Substance abuse

UR - http://www.scopus.com/inward/record.url?scp=42949100288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949100288&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2007.05.009

DO - 10.1016/j.jsat.2007.05.009

M3 - Article

C2 - 17664052

AN - SCOPUS:42949100288

VL - 34

SP - 456

EP - 459

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 4

ER -